Association between Vitamin D Deficiency and Anemia in Patients with End-Stage Renal Disease: A Cross-Sectional Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Despite new treatment strategies, anemia remains the most prevalent complication in patients with end-stage renal disease (ESRD). We investigated whether 25-hydroxyvitamin D [25(OH)D3] deficiency was associated with anemia in ESRD patients. Materials and Methods: We reviewed the medical records of 410 ESRD patients who had undergone renal transplantation (RTx) at Yonsei University Health System and who had 25(OH)D3 levels measured at the time of RTx. Patients were divided into two groups based on baseline 25(OH)D3 concentrations: group 1, 25(OH)D3 levels <10 ng/mL; and group 2, 25(OH)D3 levels ≥10 ng/mL. Results: Using multivariate regression models, 25(OH)D3, age, and erythrocyte-stimulating agent (ESA) dose were found to be significantly associated with hemoglobin (Hb) levels [25(OH)D3: β=0.263, p<0.001; age: β=0.122, p=0.010; ESA dose: β=-0.069, p=0.005]. In addition, logistic regression analysis revealed that patients in group 1 had a significantly higher risk for developing anemia (Hb level <10 g/dL) compared to group 2 patients, even after adjusting for potential risk factors for anemia (odds ratio=3.857; confidence interval=1.091–13.632; p=0.036). Conclusion: 25(OH)D3 deficiency was significantly associated with anemia in patients with ESRD. Randomized controlled trials are needed to determine whether vitamin D supplementation can improve anemia in these patients.
Abstract
Purpose: Despite new treatment strategies, anemia remains the most prevalent complication in patients with end-stage renal disease (ESRD). We investigated whether 25-hydroxyvitamin D [25(OH)D3] deficiency was associated with anemia in ESRD patients. Materials and Methods: We reviewed the medical records of 410 ESRD patients who had undergone renal transplantation (RTx) at Yonsei University Health System and who had 25(OH)D3 levels measured at the time of RTx. Patients were divided into two groups based on baseline 25(OH)D3 concentrations: group 1, 25(OH)D3 levels <10 ng/mL; and group 2, 25(OH)D3 levels ≥10 ng/mL. Results: Using multivariate regression models, 25(OH)D3, age, and erythrocyte-stimulating agent (ESA) dose were found to be significantly associated with hemoglobin (Hb) levels [25(OH)D3: β=0.263, p<0.001; age: β=0.122, p=0.010; ESA dose: β=-0.069, p=0.005]. In addition, logistic regression analysis revealed that patients in group 1 had a significantly higher risk for developing anemia (Hb level <10 g/dL) compared to group 2 patients, even after adjusting for potential risk factors for anemia (odds ratio=3.857; confidence interval=1.091–13.632; p=0.036). Conclusion: 25(OH)D3 deficiency was significantly associated with anemia in patients with ESRD. Randomized controlled trials are needed to determine whether vitamin D supplementation can improve anemia in these patients.
참고문헌 (28)
- Astor BC, "Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)", Arch Intern Med, 162, pp.1401~1408 (2002)
- Golbahar J, "Association of vitamin D deficiency and hyperparathyroidism with anemia: a crosssectional study", J Blood Med, 4, pp.123~128 (2013)
- Wittwer I, "Iron deficiency anaemia in chronic kidney disease", J Ren Care, 39, pp.182~188 (2013)
- Wojcicki JM, "Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010", BMC Nephrol, 14, pp.178~ (2013)
- Shimizu Y, "Arima K, et al. Association between alkaline phosphatase and anemia in rural Japanese men: The Nagasaki Islands study", Acta Medica Nagasakiensia, 58, pp.125~130 (2014)
- Icardi A, "Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation", Nephrol Dial Transplant, 28, pp.1672~1679 (2013)
- Besarab A, "Iron supplementation to treat anemia in patients with chronic kidney disease", Nat Rev Nephrol, 6, pp.699~710 (2010)
- Patel NM, "Vitamin D deficiency and anemia in early chronic kidney disease", Kidney Int, 77, pp.715~720 (2010)
- Kendrick J, "25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease", Am J Nephrol, 30, pp.64~72 (2009)
- Yoo EH, "Prevalence of 25-hydroxyvitamin D deficiency in Korean patients with anemia", J Clin Lab Anal, 29, pp.129~134 (2015)
- Hollis BW, "Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer", Clin Chem, 39, pp.529~533 (1993)
- Holick MF, "Vitamin D deficiency", N Engl J Med, 357, pp.266~281 (2007)
- Holick MF, "High prevalence of vitamin D inadequacy and implications for health", Mayo Clin Proc, 81, pp.353~373 (2006)
- Bischoff-Ferrari HA, "Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes", Am J Clin Nutr, 84, pp.18~28 (2006)
- Thomas MK, "Hypovitaminosis D in medical inpatients", N Engl J Med, 338, pp.777~783 (1998)
- Malabanan A, "Redefining vitamin D insufficiency", Lancet, 351, pp.805~806 (1998)
- Moorthi RN, "Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question", Curr Opin Nephrol Hypertens, 20, pp.354~359 (2011)
- Coyne DW, "The KDOQI US commentary on KDIGO anemia guideline and quality of life", Am J Kidney Dis, 63, pp.540~ (2014)
- Cana˘-Ruiu D, "Renal anemia -risk factor for chronic kidney disease", Curr Health Sci J, 39, pp.214~217 (2013)
- Hörl WH, "Anaemia management and mortality risk in chronic kidney disease", Nat Rev Nephrol, 9, pp.291~301 (2013)
- Cases-Amenós A, "Prevalence of anaemia and its clinical management in patients with stages 3-5 chronic kidney disease not on dialysis in Catalonia: MICENAS I study", Nefrologia, 34, pp.189~198 (2014)
- Chang JM, "Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease", Am J Med Sci, 347, pp.183~189 (2014)
- Tirmenstajn-Jankovic B, "Anemia is independently associated with NT-proBNP levels in asymptomatic predialysis patients with chronic kidney disease", Hippokratia, 17, pp.307~312 (2013)
- Hung SC, "Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines", Nephrology (Carlton), 19, pp.735~739 (2014)
- Aucella F, "Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure. A synergistic effect with r-HuEpo", Nephron Clin Pract, 95, pp.c121~c127 (2003)
- Aucella F, "Calcitriol increases burst forming unit-erythroid (BFU-E) in vitro proliferation in chronic uremia. Synergic effect with DNA recombinant erythropoietin (rHu-Epo)", Minerva Urol Nefrol, 53, pp.1~5 (2001)
- Zughaier SM, "The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes", J Clin Transl Endocrinol, 1, pp.19~25 (2014)
- Brancaccio D, "Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach", J Am Soc Nephrol, 15(Suppl 1), pp.S21~S24 (2004)